Used primarily as a metabolite and reference standard in pharmaceutical research for studying the metabolism and pharmacokinetics of erlotinib, a tyrosine kinase inhibitor. Plays a role in assessing drug interactions and bioavailability in cancer treatments, particularly in non-small cell lung cancer. Also utilized in analytical testing to validate assays and monitor therapeutic drug levels in patient plasma.